A NEW GENERATION OF IMMUNOTHERAPIES
AyuVis Research, Inc. is developing a new generation of immunotherapies that, rather than simply activating or suppressing the immune response,
provide a well-balanced outcome where both mild activation and controlled suppression of the immune system is needed to effectively treat disease.
This process allows us to control both inflammation and infection.
Our drug candidates were designed with 3 things in mind, being:
-
Easy to manufacture
-
Simple to formulate
-
Safe with no toxicity in humans
Unlike these previous generations of immunotherapy, AyuVis compounds target the white blood cells in the innate immune system to provide a rapid response
Immunotherapies for autoimmune diseases and cancer have annual worldwide sales of more than:
$70 Billion
OUR TEAM
Click the button to meet our top team of scientists, advisors, and administrators
Our Team
OUR NEWS & EVENTS
Keep up with the latest busines and scientific progress
News & Events
OUR PIPELINE
A pipeline like no other